NRXP · NRX Pharmaceuticals
The AI's read
The report offers no new information about NRX Pharmaceuticals' business. A share-price jump alone does not show a change in its business outlook, so this story leaves that outlook unchanged.
NRX Pharmaceuticals shares rose 12% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
The report offers no new information about NRX Pharmaceuticals' business. A share-price jump alone does not show a change in its business outlook, so this story leaves that outlook unchanged.
Intensity Therapeutics shares rose about 10% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
iSpecimen shares rose about 9% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
Entera Bio shares rose about 9% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
Clearmind Medicine shares rose about 9% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
Psyence Biomedical shares rose about 9% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
Follow NRX Pharmaceuticals (NRXP) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NRXP